drugset / Trial / NCT03012763

Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums

NCT03012763

Phase 1 Completed 9 enrolled University Medicine Greifswald
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine pharmacokinetics of the probe-drugs sulfasalazine, given in 240 ml non-caloric water and paracetamol, fexofenadine and valsartan after oral administration, given in 240 ml non-caloric water, in 240 ml caloric drink or in 240 ml grapefruit juice prior to ingestion and to visualize the localization and to measure the filling volume of stomach, small intestine as well as ascending, transverse and descending colon by T2-weighted magnetic resonance imaging after oral administration of 240 ml water (non-caloric water), after administration of 240 ml caloric drink and after administration of 240 ml grapefruit juice.

Timeline

Start
2016-04
Primary completion
2017-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 250 mg Oral
Comparator Fexofenadine Unknown 120 mg Oral
Comparator Sulfasalazine Small molecule 50 mg Oral
Comparator Valsartan Small molecule 40 mg Oral

Indications

No indication recorded.